BPTH vs. RPXIX

In the year-to-date period, BPTH achieves a -30.40% return, which is significantly lower than RPXIX's 3.98% return. Over the past 10 years, BPTH has underperformed RPXIX with an annualized return of -60.93%, while RPXIX has yielded a comparatively higher 4.97% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Bio-Path Holdings, Inc. (BPTH) and RiverPark Large Growth Fund (RPXIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BPTH Sharpe Ratio is -0.52, which is lower than the RPXIX Sharpe Ratio of 0.79. The chart below compares the historical Sharpe Ratios of BPTH and RPXIX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither BPTH nor RPXIX has paid dividends to shareholders.

The maximum BPTH drawdown since its inception was -100.00%, which is greater than RPXIX's maximum drawdown of -59.98%. Use the drawdown chart below to compare losses from any high point for BPTH and RPXIX. For additional features, visit the drawdowns tool.

Bio-Path Holdings, Inc. (BPTH) has a higher volatility of 17.82% compared to RiverPark Large Growth Fund (RPXIX) at 4.63%. This indicates that BPTH's price experiences larger fluctuations and is considered to be riskier than RPXIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.